Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Gilead’s Dietmar Berger Reflects On Pipeline After First Year As CMO
Gilead’s Chief Medical Officer, Dietmar Berger, reflects on the company’s pipeline after his first year in the role, focusing on advancements beyond HIV into new modalities in cancer. The article highlights upcoming milestones in 2026 for both HIV and cancer treatments, underscoring Gilead’s strategic direction in drug development. Key developments mentioned include new approvals and trial data for various therapies.